Cargando…
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma
BACKGROUND: MiRNAs act as negative regulators of gene expression through target mRNA degradation or inhibition of its translation. In cancer, several miRNAs are upregulated and play crucial roles in tumorigenesis, making the inhibition of these oncomiRs an interesting therapeutic approach. This can...
Autores principales: | Kunz, Manfred, Brandl, Madeleine, Bhattacharya, Animesh, Nobereit-Siegel, Lars, Ewe, Alexander, Weirauch, Ulrike, Hering, Doreen, Reinert, Anja, Kalwa, Hermann, Guzman, Juan, Weigelt, Katrin, Wach, Sven, Taubert, Helge, Aigner, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685669/ https://www.ncbi.nlm.nih.gov/pubmed/33228711 http://dx.doi.org/10.1186/s12951-020-00728-w |
Ejemplares similares
-
Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
por: Devulapally, Rammohan, et al.
Publicado: (2015) -
Inhibition of microRNA function by antimiR oligonucleotides
por: Stenvang, Jan, et al.
Publicado: (2012) -
MicroRNA inhibition using antimiRs in acute human brain tissue sections
por: Morris, Gareth, et al.
Publicado: (2022) -
Transmission of microRNA antimiRs to mouse offspring via the maternal–placental–fetal unit
por: Hönig, Jonas, et al.
Publicado: (2018) -
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
por: González-Martínez, Irene, et al.
Publicado: (2023)